|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Basilea Pharmaceutica Ltd., of Basel, Switzerland, said it has submitted a marketing authorization application for ceftobiprole for the treatment of complicated skin and soft tissue infections to Swissmedic by its license partner Janssen-Cilag AG, a Johnson & Johnson company. The product previously had achieved accelerated assessment for its marketing authorization. Ceftobiprole currently is under review by regulatory authorities in the U.S., Canada and in the European Union. Ceftobiprole is being developed through an exclusive worldwide collaboration between Basilea Pharmaceutica Ltd. and Cilag GmbH International.
o Bioniche Life Sciences Inc., of Belleville, ...